- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07927530
Ultrasound-Guided Thoracolumbar Fascia Injection for Chronic Low Back Pain in Patients With Type 2 Diabetes
Efficacy of Ultrasound-Guided Thoracolumbar Fascia Injection in the Treatment of Chronic Low Back Pain in Patients With Type 2 Diabetes Mellitus: A Randomized Controlled Trial
This prospective, randomized, controlled clinical trial aims to evaluate the efficacy of ultrasound-guided thoracolumbar fascia (TLF) injection as an adjunct to standard conservative treatment in patients with type 2 diabetes mellitus and chronic nonspecific low back pain.
A total of 60 patients aged 18-65 years, diagnosed with type 2 diabetes mellitus for at least one year and experiencing chronic nonspecific low back pain for at least three months, will be enrolled. Eligible participants will be randomly assigned to two groups. The intervention group will receive ultrasound-guided thoracolumbar fascia injection in addition to standard conservative treatment, while the control group will receive standard conservative treatment alone, consisting of patient education and a structured exercise program.
Clinical assessments will be performed at baseline and at 1 and 3 months after treatment. Treatment outcomes will include pain intensity measured using the Numeric Rating Scale (NRS), functional disability assessed using the Oswestry Disability Index (ODI), pressure pain threshold (PPT) measured by algometry, and analgesic consumption.
Thoracolumbar fascia thickness will be measured using ultrasonography at baseline to investigate its potential association with treatment response. Diabetes-related characteristics, including HbA1c levels, diabetes duration, and peripheral neuropathy status, will also be recorded.
The primary objective is to determine whether adding ultrasound-guided thoracolumbar fascia injection to standard conservative treatment provides greater improvement in pain intensity and functional disability compared with standard conservative treatment alone. The study will also explore whether baseline thoracolumbar fascia thickness and diabetes-related characteristics are associated with clinical outcomes.
Visão geral do estudo
Status
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Hatice Zehra FERHATLAR, MD
- Número de telefone: 05367387869
- E-mail: haticezehraferhatlar@gmail.com
Locais de estudo
-
-
Istanbul
-
Küçükçekmece, Istanbul, Turquia (Türkiye), 34307
- Recrutamento
- Kanuni Sultan Suleyman Training and Research Hospital
-
Contato:
- Hatice Zehra FERHATLAR, MD
- Número de telefone: 05367387869
- E-mail: haticezehraferhatlar@gmail.com
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
**Inclusion Criteria:**
- Age between 18 and 65 years.
- Diagnosis of type 2 diabetes mellitus for at least 1 year.
- Chronic low back pain lasting at least 3 months.
- Nonspecific or mechanical low back pain.
- Baseline pain intensity of ≥4 on the Numeric Rating Scale (NRS).
- Pain or tenderness on palpation over the thoracolumbar fascia region.
- Willingness to participate in the study.
- Provision of written informed consent.
**Exclusion Criteria:**
- Radiculopathy or significant neurological deficits.
- Neurogenic claudication due to spinal stenosis.
- Spinal tumor or infection.
- History or presence of vertebral fracture.
- Inflammatory rheumatic disease.
- Spinal surgery within the previous 6 months.
- Injection in the lumbar region within the previous 3 months.
- Anticoagulant therapy or conditions contraindicating injection.
- Active infection at the injection site.
- Severe systemic disease, including advanced renal failure.
- Uncontrolled diabetic metabolic condition.
- Pregnancy.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Thoracolumbar Fascia Injection Group
|
A single ultrasound-guided thoracolumbar fascia injection will be performed with the patient in the prone position under aseptic conditions. Using an in-plane technique, a 22-gauge needle will be advanced into the middle layer of the thoracolumbar fascia between the quadratus lumborum and erector spinae muscles at the L4 level. Correct needle placement will be confirmed by hydrodissection using approximately 2 mL of local anesthetic. Subsequently, 10 mL of 0.25% bupivacaine and 40 mg of methylprednisolone acetate will be administered into the interfascial plane. Standard conservative treatment will consist of structured patient education and a home-based exercise program. The exercise program will include lumbopelvic and core stabilization exercises, abdominal and paraspinal muscle strengthening, hip muscle strengthening, lower extremity stretching, and aerobic activity as tolerated. Participants will receive instructions on correct exercise techniques, maintaining daily activities, and avoiding prolonged bed rest. The program will be recommended for regular home practice throughout the study period. |
|
Comparador Ativo: Standard Conservative Treatment Group
|
Standard conservative treatment will consist of structured patient education and a home-based exercise program. The exercise program will include lumbopelvic and core stabilization exercises, abdominal and paraspinal muscle strengthening, hip muscle strengthening, lower extremity stretching, and aerobic activity as tolerated. Participants will receive instructions on correct exercise techniques, maintaining daily activities, and avoiding prolonged bed rest. The program will be recommended for regular home practice throughout the study period. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Prazo |
|---|---|
|
Change in Low Back Pain Intensity Measured by the Numeric Rating Scale (NRS)
Prazo: Baseline, Month 1, and Month 3
|
Baseline, Month 1, and Month 3
|
Medidas de resultados secundários
Medida de resultado |
Prazo |
|---|---|
|
Change in Functional Disability Measured by the Oswestry Disability Index (ODI)
Prazo: Baseline, Month 1, and Month 3
|
Baseline, Month 1, and Month 3
|
|
Change in Pressure Pain Threshold (PPT) Measured by Algometry
Prazo: Baseline, Month 1, and Month 3
|
Baseline, Month 1, and Month 3
|
|
Change in Analgesic Consumption During Follow-up
Prazo: Baseline to Month 3
|
Baseline to Month 3
|
Colaboradores e Investigadores
Patrocinador
Publicações e links úteis
Publicações Gerais
- Ahiskalioglu A, Yayik AM, Celik EC, Aydin ME, Uzun G. Ultrasound guided modified Thoracolumbar Interfascial Plane block for low back pain management. J Clin Anesth. 2019 May;54:138-139. doi: 10.1016/j.jclinane.2018.11.010. Epub 2018 Nov 28. No abstract available.
- Okmen BM, Okmen K. Effectiveness of the Ultrasound-Guided Interfascial Injection Applied in Addition to Physical Therapy Applications in Chronic Low Back Pain: A Quasi-Experimental Study. Eurasian J Med. 2024 Feb;56(1):56-60. doi: 10.5152/eurasianjmed.2024.23286.
- Lv Y, Wu J, Xu Y, Pu S, Li C, Du D. A novel approach to ultrasound-guided L3-4 thoracolumbar fascia injection for chronic pain after spine surgery: a prospective pilot study. BMC Anesthesiol. 2025 May 15;25(1):243. doi: 10.1186/s12871-025-03046-6.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- TLF-DM-RCT-2026
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .